The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 241-245

Karger

Access to resources Recommend Favorite

Oral Iron Chelator Deferasirox in the Treatment of Secondary Hemochromatosis following Bone Marrow Transplantation in a Patient with Severe Aplastic Anemia

By  

Acta Haematologica, Vol. 125, Iss. 4, 2011-01 ,pp. : 219-221

Karger

Access to resources Recommend Favorite

Antifibrotic activity of deferasirox

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 3, 2015-03 ,pp. : 638-645

John Wiley & Sons Inc

Access to resources Recommend Favorite

The oral iron chelator deferasirox inhibits NF‐κB mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 168, Iss. 4, 2015-02 ,pp. : 576-582

John Wiley & Sons Inc

Access to resources Recommend Favorite

The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 170, Iss. 2, 2015-07 ,pp. : 236-246

John Wiley & Sons Inc

Access to resources Recommend Favorite